Susquehanna International Group, LLP Onconova Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.71 - $1.15 $21,806 - $35,319
30,713 New
30,713 $21,000
Q1 2023

May 16, 2023
BUY
$0.69 - $1.42 $19,592 - $40,320
28,395 New
28,395 $20,000
Q2 2022

Aug 15, 2022
SELL
$1.04 - $1.9 $17,677 - $32,296
-16,998 Reduced 56.0%
13,356 $18,000
Q3 2021

Nov 15, 2021
BUY
$3.81 - $6.76 $115,648 - $205,193
30,354 New
30,354 $116,000

Others Institutions Holding ONTX

# of Institutions
3
Shares Held
249K
Call Options Held
0
Put Options Held
0
View Full List

About Onconova Therapeutics, Inc.

ONTX Quotes by TradingView
  • Ticker ONTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,895,600
  • Market Cap $12.3M
  • Description
  • Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...
More about ONTX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email